1. 6 Interpreting immune infiltrates and hormone biomarkers in young women with endometrial carcinoma (EC) through a moder lens (POST-TCGA) of molecular classification. (18th September 2019) Authors: Farnell, D; Leung, S; Britton, H; Lum, A; Tessier-Cloutier, B; Huang, L; Shum, K; Kale, M; Yang, W; Kommoss, S; Brucker, S; Talhouk, A; Huntsman, DG; Gilks, CB; McAlpine, J Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 6 Variation in practice in endometrial cancer (EC); can molecular classification direct care and reduce costs associated with management?. (13th November 2020) Authors: Thompson, E; Lum, A; Huvila, J; Scott, S; Lui, V; He, E; Salisbury, T; Keane, S; Keane, S; Samouelian, V; Irving, J; Salvador, S; Helpman, L; Wohlmuth, C; Kinloch, M; Offman, S; Vicus, D; Grondin, K; Gtlieb, W; Plante, M Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tubal origin of ovarian high‐grade serous carcinoma—time to let go of the wrong end of the stick. (15th March 2017) Authors: Singh, N; Gilks, CB Journal: BJOG Issue: Volume 124:Number 6(2017) Page Start: 879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗